SuperworthAldeyra Therapeutics shares outstanding ALDX
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 60.3M
- On a year earlier
- +0.5%
- more shares
Aldeyra Therapeutics had 60.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is about the same as a year earlier.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 60.2M | +1% |
| FY2024 | 59.6M | +1% |
| FY2023 | 59.2M | +1% |
| FY2022 | 58.6M | +1% |
| FY2021 | 58.1M | +50% |
| FY2020 | 38.6M | +40% |
| FY2019 | 27.7M | +6% |
| FY2018 | 26.2M | +37% |
| FY2017 | 19.1M | +52% |
| FY2016 | 12.6M | +29% |
| FY2015 | 9.7M | +75% |
| FY2014 | 5.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 60.3M | +0% | |
| Q1 FY26 | 60.3M | +1% | |
| Q4 FY25 | 60.2M | +1% | |
| Q3 FY25 | 60.1M | +1% | |
| Q2 FY25 | 60M | +1% | |
| Q1 FY25 | 59.9M | +1% | |
| Q4 FY24 | 59.6M | +1% | |
| Q3 FY24 | 59.5M | +1% | |
| Q2 FY24 | 59.4M | +1% | |
| Q1 FY24 | 59.4M | +1% | |
| Q4 FY23 | 59.2M | +1% | |
| Q3 FY23 | 59M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Aldeyra Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.